News All Investor Product Commitment Other Year All 2007 2006 2005 2004 2003 2002 2008 Language English Icelandic

News

• 10.07.2008 / Product Actavis generic prostate cancer drug Bicalutamide first to market in UK, Germany, France

  Actavis today announced the launch of Bicalutamide tablets in the United Kingdom, Germany and France. Bicalutamide Actavis is the first generic version of the oncology drug to be made available in

• 02.07.2008 / Product Actavis divests 7 products in Poland as part of ongoing integration

  Actavis has sold a product portfolio of 7 established brands to Glenmark Pharmaceuticals Ltd. for an undisclosed sum. The agreement with Glenmark is effective from 1 July 2008. The divestment of

• 30.05.2008 / Commitment Actavis receives ISO and OHSAS certificates in Serbia

  Zdravlje Actavis in Serbia has been formally presented with certificates for the international standards ISO 9001:2000 (quality) and ISO 14001 (environment), as well as OHSAS 18001 (occupational

  ---

• 30.05.2008 / Commitment Actavis builds second ramp for disabled in Bulgaria
• 26.05.2008 / Other Robert Wessman to present at annual UBS pharmaceuticals conference
• 16.05.2008 / Other Actavis signs distribution agreement with Generic Health in Australia
• 09.05.2008 / Product Customer support and frequently asked questions on Digitek recall
• 25.04.2008 / Product Actavis Totowa (formerly known as Amide Pharmaceutical, Inc.) recalls all lots of Bertek and UDL Laboratories Digitek (digoxin tablets, USP) as a precaution
• 24.04.2008 / Other Harvard publishes case study on Robert Wessman and Actavis
• 09.04.2008 / Other Actavis acquires API manufacturing company in China